1. Alcohol and bone: review of dose effects and mechanisms

   • D. B. Maurel
   • N. Boisseau
   • C. Jaffre

   Review 17 September 2011 Pages: 1 - 16

   

2. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis

   • J. A. Knopp-Sihota
   • C. V. Newburn-Cook
   • D. Voaklander

   Review 10 June 2011 Pages: 17 - 38

   

3. The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women—a systematic review and meta-analysis of randomized controlled trials

   • I. Polidoulis
   • J. Beyene
   • A. M. Cheung

   Review 03 August 2011 Pages: 39 - 51

   

4. Predictors of new and severe vertebral fractures: results from the HORIZON Pivotal Fracture Trial

   • R. Wustrack
   • E. Seeman
   • D. M. Black

   Original Article 21 June 2011 Pages: 53 - 58

   

5. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS)

   • L. Ferrar
   • C. Roux
   • R. Eastell

   OriginalPaper 06 July 2011 Pages: 59 - 65

   

6. Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study

   • L. L. Laslett
   • S. J. Just nee Foley
   • G. Jones

   Original Article 18 August 2011 Pages: 67 - 74

   

7. Fracture risk assessment without bone density measurement in routine clinical practice

   • W. D. Leslie
   • S. Morin
   • for the Manitoba Bone Density Program

   Original Article 18 August 2011 Pages: 75 - 85

   

8. Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial

   • S. B. Jaglal
   • O. S. Donescu
   • M. Zwarenstein

   Original Article Open access 16 July 2011 Pages: 87 - 95

   

9. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study

   • M. S. Cooper
   • A. J. Palmer
   • M. J. Seibel

   Original Article 28 September 2011 Pages: 97 - 107

   

10. A meta-analysis of brief high-impact exercises for enhancing bone health in premenopausal women

    • O. O. Babatunde
    • J. J. Forsyth
    • C. J. Gidlow

    Original Article 28 September 2011 Pages: 109 - 119

    

11. Physical activity, calcium intake and childhood bone mineral: a population-based cross-sectional study

    • N. C. Harvey
    • Z. A. Cole
    • The SWS Study Group

    Original Article 12 May 2011 Pages: 121 - 130

    

12. Meta-analysis of gene-based genome-wide association studies of bone mineral density in Chinese and European subjects

    • C.-L. Cheung
    • P.-C. Sham
    • A. W.-C. Kung

    Original Article Open access 17 September 2011 Pages: 131 - 142

    

13. Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis

    • A. Moayyeri
    • J. E. Adams
    • E. M. Lewiecki

    Original Article 27 October 2011 Pages: 143 - 153

    

14. Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women

    • B. Srinivasan
    • D. L. Kopperdahl
    • S. Khosla

    Original Article 05 November 2011 Pages: 155 - 162

    

15. Combination of texture analysis and bone mineral density improves the prediction of fracture load in human femurs

    • T. Le Corroller
    • J. Halgrin
    • P. Champsaur

    Original Article 08 July 2011 Pages: 163 - 169

    

16. Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density

    • A. Cohen
    • R. R. Recker
    • E. Shane

    Original Article 02 March 2011 Pages: 171 - 182

    

17. Pattern of use of DXA scans in men: a cross-sectional, population-based study

    • M. Frost
    • C. Gudex
    • B. Abrahamsen

    Original Article 26 February 2011 Pages: 183 - 191

18. Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

    • O. Bruyère
    • R. Rizzoli
    • J.-Y. Reginster

    Original Article Open access 25 February 2011 Pages: 193 - 199

19. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial

    • G. Grimnes
    • R. Joakimsen
    • R. Jorde

    Original Article 10 September 2011 Pages: 201 - 211

    

20. A reappraisal of generic bisphosphonates in osteoporosis

    • J. A. Kanis
    • J.-Y. Reginster
    • C. Cooper

    Original Article Open access 28 September 2011 Pages: 213 - 221

    

21. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

    • P. Hadji
    • V. Claus
    • T. Steinle

    Original Article 10 February 2011 Pages: 223 - 231

    

22. Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials

    • E. Barrett-Connor
    • A. S. Swern
    • A. C. Santora

    Original Article Open access 03 March 2011 Pages: 233 - 245

    

23. Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis

    • C. W. Rhee
    • J. Lee
    • B. J. Park

    Original Article 24 March 2011 Pages: 247 - 254

    

24. Erratum to: Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis

    • C. W. Rhee
    • J. Lee
    • B. J. Park

    Erratum 15 November 2011 Pages: 255 - 255

25. Effect of monthly ibandronate on hip structural geometry in men with low bone density

    • H. K. Genant
    • E. M. Lewiecki
    • M. Fries

    Original Article 03 August 2011 Pages: 257 - 265

    

26. Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet

    • M. R. McClung
    • P. D. Miller
    • R. R. Recker

    Original Article Open access 27 September 2011 Pages: 267 - 276

    

27. Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors

    • C. Roux
    • J. L. Goldstein
    • R. Lindsay

    Original Article 02 March 2011 Pages: 277 - 284

    

28. Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists

    • L. A. Bradbury
    • S. Barlow
    • E. L. Duncan

    Original Article 08 July 2011 Pages: 285 - 294

    

29. The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years

    • E. T. Middleton
    • S. A. Steel
    • S. M. Doherty

    Original Article 28 January 2011 Pages: 295 - 303

    

30. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis

    • R. Rizzoli
    • R. D. Chapurlat
    • D. Felsenberg

    Original Article 10 September 2011 Pages: 305 - 315

    

31. Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

    • N. Freemantle
    • S. Satram-Hoang
    • on behalf of the DAPS Investigators

    Original Article Open access 17 September 2011 Pages: 317 - 326

    

32. Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

    • N. B. Watts
    • C. Roux
    • S. Ferrari

    Original Article Open access 03 September 2011 Pages: 327 - 337

    

33. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys

    • C. Jerome
    • M. Missbach
    • R. Gamse

    Original Article 05 March 2011 Pages: 339 - 349

    

34. Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

    • S. L. Silverman
    • A. A. Chines
    • for the Bazedoxifene Study Group

    Original Article 21 July 2011 Pages: 351 - 363

    

35. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies

    • Q. Wu
    • A. F. Bencaz
    • M. D. Crowell

    Original Article 09 September 2011 Pages: 365 - 375

    

36. Deletion of estrogen receptor beta accelerates early stage of bone healing in a mouse osteotomy model

    • Y.-X. He
    • Z. Liu
    • G. Zhang

    Original Article 27 October 2011 Pages: 377 - 389

    

37. High fracture probability with FRAX^® usually indicates densitometric osteoporosis: implications for clinical practice

    • W. D. Leslie
    • S. R. Majumdar
    • for the Manitoba Bone Density Program

    Short Communication 02 March 2011 Pages: 391 - 397

38. Validation of cross-sectional studies with long-term longitudinal studies

    • C. Cure-Cure
    • P. Cure

    Letter to the Editor 10 September 2011 Pages: 399 - 399